Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00373347
Status:
RECRUITING
Last Update Posted:
2024-02-22
First Post:
2006-09-06
Brief Title:
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy so that it can be used alone or in conjunction with alpha-feto protein AFP
Detailed Description:
Liver cancer is a deadly cancer that is typically hard to diagnose and treat The currently used blood marker for the clinical diagnosis of liver cancer is alpha-feto protein AFP which misses 40-60 of patients with liver cancer because it lacks sufficient specificity and sensitivity The purpose of this study is to identify blood markers that have the ability to diagnose liver cancer with improved accuracy so that it can be used alone or in conjunction with AFP The aim of this study is to identify new blood markers of liver cancer that can be used to increase the rate of accurate diagnosis of this malignancy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 10767 | OTHER | Stanford IRB | None |
| 95521 | OTHER | None | None |
| HEP0006 | OTHER | None | None |